Navigation Links
Combining NSAIDs With Chemotherapy May Improve Cancer Therapy

combine celecoxib with chemotherapies for head and neck cancer."

Trask's research team included Jonathan Bock, M.D., a UI resident in otolaryngology and lead author of the two studies published in recent issues of the journals Molecular Carcinogenesis and Cancer Research. Prabhat Goswami, Ph.D., UI assistant professor, and Frederick Domann, Ph.D., UI professor, both faculty in radiation oncology and in the Free Radical and Radiation Biology Graduate Program, also were part of the UI team. Trask, Goswami and Domann all are members of the Holden Comprehensive Cancer Center at the UI.

Goswami and Domann added that when radiation is used to treat head and neck cancers after surgery, the cells most resistant to radiation therapy are in the S phase. Thus celecoxib's selective killing of cells in S phase suggests this class of drug may target the radio-resistant cells, and use of the drug together with radiation might provide better tumor control than radiation alone.

Because inflammation is thought to play a role in the development of certain cancers, numerous studies have investigated the role of nonsteroidal anti-inflammatory drugs in cancer prevention. However, few studies have systematically evaluated the relative anticancer activity of different NSAIDS.

In one study, published in the April 5 online issue of Molecular Carcinogenesis, the UI scientists tested 10 commercially available NSAIDs against head and neck cancer cells. They found that celecoxib and sulindac sulfide, (sold as Clinoril sulfide) are particularly effective at slowing cancer cell proliferation and at killing cancer cells. Of these two, celecoxib is by far the most potent, killing up to 60 percent of head and neck cancer cells under the study conditions. None of the other 10 NSAIDs in the study, including aspirin, naproxen (Aleve) or rofecoxib (Vioxx), showed effective anticancer activity.

The experiments also indicated that celeco
'"/>




Page: 1 2 3

Related medicine news :

1. Tamiflu Shortage Can Be Better Handled By Combining It With Probenecid
2. Combining Therapies can Improve Survival for Early-stage Breast Cancer Patients
3. The Effectiveness Of NSAIDs Evaluated
4. NSAIDs In First trimester Linked To Congenital Anomalies In Babies
5. Study Explains How NSAIDs Halt Cancer Growth
6. Aspirin Or NSAIDs Will not Prevent Colorectal Cancer
7. Acupuncture May Help Chemotherapy Side Effects
8. Chemotherapy Pill Has Fewer Side Effects Than IV
9. Survival rates in breast cancer patients improved with "Dose Dense Chemotherapy"
10. Therapy Boosts Chemotherapy Effects
11. Chemotherapy Effective for Bladder Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Combining NSAIDs With Chemotherapy May Improve Cancer Therapy

(Date:7/6/2015)... ... July 06, 2015 , ... Acara Partners, ... announces the return of its complimentary educational webinar series for the ... leaders creates success for their clients through targeted marketing, sales, digital communications, branding ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... proper reimbursement for radiology services and ADVOCATE is leading the transition. ADVOCATE, the ... coding expertise with their Top 10 Tips for ICD-10. The ten tips are ...
(Date:7/6/2015)... ... , ... Health care systems and genomics projects have generated massive patient data ... use this “Big Data” to improve health and cut costs is now on the ... Sinai Health System in New York City. Physicians will have these new capabilities within ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... received nearly $400,000 in grant funds to support a three-year effort to reduce ... The work will be conducted in partnership with the Morehouse School of Medicine’s ...
(Date:7/6/2015)... ... July 06, 2015 , ... Diabetes affects many of us ... 29 million Americans have diabetes, the majority of which are Type 2. However, eight ... more than one in three, have prediabetes (abnormally high blood sugar levels). Without reductions ...
Breaking Medicine News(10 mins):Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 3Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 4Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 5Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2Health News:115 Million in the U.S. could beat diabetes with the help of a new app 2
... same breast cancer treatments as Hispanic and white women ... were more likely to be diagnosed// with later-stage cancer ... ,For the study, lead researcher Wendy ... Cancer Center and colleagues examined 2,140 women participating in ...
... weight loss drugs are really safe, an analysis of previous ... was conducted. What// came to light was the lack of ... ,Two Canadian researchers, Raj Padwal and Sumit Majumdar of ... like sibutramine (Meridia), orlistat (Xenical) and rimonabant (Acomplia) are no ...
... near toxic waste may make you diabetic, says a study ... 1993 and 2000.// ,Type-two diabetes has seen a ... from 1980 to 2002. While scientists scramble to find explanations ... the growing diabetes rate. , ,However, the study by ...
... Carolina State University toxologists and Rice University Chemists// has ... intake speed of nanoparticles through the skin. Vitro experiments ... of the research. These bucky balls contained amino acids. ... with the increasing degree of flexing of the skin. ...
... and Prevention (CDC) Atlanta's Division of Tuberculosis Elimination feel ... and made TB tests mandatory for all foreign-born nationals, ... ,Tuberculosis can only be eradicated if all ... necessary, treated for latent TB infection, they say. ...
... Dentists at the Manchester University have developed a new ... x-rays//. This is done by automatically measuring the width ... ,Professor Keith Horner and Dr Hugh Devlin at ... modeling’ technology that was developed by the Division of ...
Cached Medicine News:Health News:Living Near Toxic Waste May Bring On Diabetes 2Health News:Nanoparticle Uptake Zoom by Repetitive Motion 2Health News:All Foreign-born Nationals In US To Be Tested For TB 2
(Date:7/6/2015)... BOSTON , July 6, 2015 ... Inc. (NASDAQ: ISIS ), announced today that ... Orphan Drug Designation to volanesorsen (ISIS-APOCIII Rx ) ... Syndrome (FCS).  FCS is a rare genetic disease ... of pancreatitis. In a Phase 2 study published ...
(Date:7/5/2015)... 6, 2015 Nihon University is pleased ... on Medical-Engineering Collaboration "Medicine Definitely Jumps Up with ... in Tokyo, Japan . Many ... research will present their achievements and future prospects ... industry produced with 8K technology. (Documentation: ...
(Date:7/3/2015)... 4, 2015 Un fournisseur ... que sont l,hypertension, le diabète et les troubles ... l,intermédiaire de plateformes éducatives gratuites et d,une conférence ... (Photo: http://photos.prnewswire.com/prnh/20150630/227090 ) , ... en ligne , Prendre en charge l,hypertension ...
Breaking Medicine Technology:Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6Nihon University to Host International Symposium on Medical-Engineering Collaboration 2Nihon University to Host International Symposium on Medical-Engineering Collaboration 3Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 3
... 23, 2007 -,Gentium S.p.A. (NASDAQ: GENT) (the ... will be the subject of a poster,presentation ... being held in,Rio de Janeiro, Brazil from ... 2007, Cinara Echart, Ph.D., Manager of,Biological Research ...
... 24 /CNW/ - The weight loss medication Xenical,(orlistat ... such as blood pressure, glycaemic,control and lipid profile ... and hypertension, according to a study analysis,presented at ... ,This analysis strengthens the wealth of data already ...
Cached Medicine Technology:Gentium's Defibrotide Highlighted in Poster Presentation at World,Congress of Nephrology 2Gentium's Defibrotide Highlighted in Poster Presentation at World,Congress of Nephrology 3New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 2New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 3New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 4New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 5New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 6
Inquire...
Superior imaging through a 410,000 pixel CCD, unseen color replication from a digital signal processor in the scope, and the added benefit of four way tip deflection make the TF410 a superior choice ...
The computer-optimized optical design produces large, brilliant images of high resolution....
ACMI™ Distortion-Free Laparoscopes utilize technical advances in optical lens design to provide images without the fish-eye effect typically found on the peripheral viewing edges of conventional...
Medicine Products: